A scrapie-positive ewe was found in a flock that had been scrapie-free for 13 years, but housed adjacent to scrapie-positive animals, separated by a wire fence. Live animal testing of the entire flock of 24 animals revealed seven more subclinical scrapie-positive ewes. We hypothesized that they may have contracted the disease from scrapie-positive rams used for breeding 4 months prior, possibly through the semen. The genotypes of the ewe flock were highly scrapiesusceptible and the rams were infected with the 'Caine' scrapie strain having a short incubation time of 4.3-14.6 months in sheep with 136/171 VQ/VQ and AQ/VQ genotypes. PrP Sc accumulates in a variety of tissues in addition to the central nervous system. Although transmission of prion diseases, or transmissible spongiform encephalopathies, has been achieved via peripheral organ or tissue homogenates as well as by blood transfusion, neither infectivity nor PrP Sc have been found in semen from scrapie-infected animals. Using serial protein misfolding cyclic amplification followed by a surround optical fibre immunoassay, we demonstrate that semen from rams infected with a short-incubation-time scrapie strain contains prion disease-associatedseeding activity that generated PrP Sc in sPMCA (serial protein misfolding cyclic amplification).
INTRODUCTION
Scrapie in sheep and goats is a transmissible spongiform encephalopathy (TSE), or prion disease, a category that also includes Creutzfeldt-Jakob disease in humans and bovine spongiform encephalopathy (BSE) in cattle (Detwiler & Baylis, 2003; Collinge, 2001) . A hallmark of TSEs is the accumulation, most prominently in the central nervous system, of an abnormally folded prion protein isoform, PrP Sc , which is derived from the host-encoded cellular form (PrP c ). PrP Sc is the only known component of infectious prions and is also assumed to be responsible for the neuropathology caused by these agents (Prusiner, 1982; Weissmann, 2004) . Diagnosis of TSE infection largely relies on the detection of the pathological isoform, which differs from PrP c by various properties, most notably an increased resistance to proteolysis (Bolton et al., 1982) .
In sheep scrapie, TSE susceptibility (incidence and age of onset of natural and experimental disease) is mainly controlled by polymorphisms at three codons in the ovine PRNP: aa 136 (A or V), 154 (R or H) and 171 (R, Q or H) (Hunter, 1996) . The genotypes V 136 R 154 Q 171 /VRQ, ARQ/ VRQ, ARQ/ARQ and VRQ/ARH PrP are most susceptible to scrapie, while the ARR/ARR and AHR/AHR alleles are associated with natural resistance to the clinical disease (Goldmann et al., 1994; Westaway et al., 1994; Belt et al., 1995; Ikeda et al., 1995; Elsen et al., 1999; Baylis et al., 2002 Baylis et al., , 2004 . Incubation time in sheep has been shown to rely on the strain of ovine scrapie as well as the genotype of the recipient sheep (Hunter et al., 1993; Goldmann et al., 1994; Bulgin et al., 2006; Hamir et al., 2009) . 'V'-dependent strains such as the SSBP/1 strain reported by Hunter and the X124 ('Caine') strain characterized by Hamir et al. (2009) have much shorter incubation times in VRQ/VRQ and ARQ/VRQ sheep, while showing more traditional incubation times in sheep with ARQ/ARQ genotypes.
Expression of PrP
C is not restricted to nervous tissues; PrP C is present in virtually all tissues in the body (Bendheim et al., 1992; Moudjou et al., 2001) . Gatti et al. (2002) demonstrated the presence of PrP C in sperm and demonstrated that it is synthesized in the genital tract where it is released in large quantities as a soluble form in the epididymal fluid and seminal plasma of the ram. Proteolytic processing of the prion protein also appears to occur at this point. However, Gatti et al. (2002) did not detect proteinase K (PK)-resistant PrP Sc in the seminal plasma from scrapie-infected animals.
The risk of TSE infectivity in semen from sheep, goats and cattle is assumed to be extremely low. Bioassays in mice have failed to detect infectivity in testis, seminal vesicles and semen of scrapie-affected rams, or in testis, epididymis, prostate, seminal vesicles and semen of BSE-affected bulls. Wrathall et al. (2002) reported that the use of semen from bulls clinically affected with BSE to inseminate clinically affected cows did not lead to BSE infection of the resulting embryos. This is not surprising due to the lack of infectivity and PrP Sc in peripheral cattle tissue from BSEinfected cattle. In contrast, sheep are known to contain both infectivity and pathology in peripheral tissues. In an early experiment, semen from a scrapie-affected ram was inoculated into 20 1-day-old lambs (Palmer, 1959) and there was no disease transmission. However, the experiment was stopped only 30 months after inoculation and no genotype information is available limiting the interpretation of the study. Wang et al. (2001 Wang et al. ( , 2002 ) mated a scrapiepositive ram with one scrapie-positive and one scrapienegative ewe. Embryos collected from these two ewes yielded seven and four offspring, respectively, which were scrapie-free at 60 months of age, suggesting that scrapie was not transmitted via the semen. However, this was not statistically significant based on the number of samples. Sarradin et al. (2008) examined semen from scrapie-infected rams at different stages of incubation, including the clinical phase of the disease, for prion infectivity. Bioassays performed with scrapie-susceptible transgenic mice overexpressing the V 136 R 154 Q 171 allele of the ovine PRNP did not result in clinical disease or PrP Sc in the brains of these mice.
Detection of PrP
Sc by a laser-based assay, surround optical fibre immunoassay (SOFIA), has recently been reported to provide increased sensitivity for animal prion diseases (Chang et al., 2009; Rubenstein et al., 2010 Rubenstein et al., , 2011 . This assay is not dependent on PK treatment for the detection of PrP Sc , which eliminates PrP C , but does require serial protein misfolding cyclic amplification (sPMCA) for detection of prion-associated-seeding activity from extremely low titre sources; the prion disease-associated-seeding activity (PASA) may not be PrP
Sc . Here, we report detection of PASA in semen by using a combination of sPMCA followed by SOFIA. We also demonstrate the presence of prion infectivity in the original semen samples by bioassays in a newly generated sheep scrapie-susceptible transgenic mouse line, TgSShpPrP. (Tables 1 and S1, available The objective of this study was to determine whether semen from clinical and subclinical scrapie-positive rams with highly susceptible genotypes (Tables 1 and Table S1 ) and a unique US strain of scrapie might contain the scrapie-transmissible agent, or PASA, and be detectable by sPMCA and SOFIA.
RESULTS
The use of SOFIA alone to detect PrP Sc in semen samples from scrapie-infected sheep was unsuccessful (data not shown). In previous studies (Rubenstein et al., 2010 (Rubenstein et al., , 2011 , we also reported that SOFIA alone was unable to detect PrP Sc in blood and urine from scrapie-infected sheep and cervids with chronic wasting disease. However, in combination with sPMCA, which utilizes PASA, PrP Sc in blood and urine was detectable. The level of PrP Sc detected was dependent on the number of serial cycles of PMCA. Furthermore, amplification is efficient independent of the genotypes of the PrP C and PrP Sc (Rubenstein et al., 2010 (Rubenstein et al., , 2011 . The level of PrP Sc measured by SOFIA following sPMCA 80 and sPMCA 120 (Fig. 1 ) was similar to that found in urine (Rubenstein et al., 2011) and significantly less than that found in blood (Rubenstein et al., 2010 ) from scrapieinfected sheep. This suggests that the PASA found in the semen of these animals is similar to that for urine from infected animals, approximately 1 attogram ml
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. However, it is not possible to determine whether prion-seeding activity is actually PrP Sc (Rubenstein et al., 2011) .
The ovinized PrP transgenic mouse line, TgSShpPrP, was analysed for ovine PrP C expression. Serial twofold dilutions of brain homogenates from TgSShpPrP mice and wild-type Semen PASA, PrP Sc and scrapie infectivity in sheep (WT) mice on the same FVB genetic background were analysed by Western blotting. PrP C was immunostained using the PrP-specific mAb, 08-6/2F7-2F11. The dilutions producing equivalent PrP C immunostaining between the two mouse lines indicate that the level of expression of sheep PrP C in the brains of TgSShpPrP mice is approximately fourfold greater than mouse PrP C in the WT mice (Fig. 2 ).
The ability of TgSShpPrP mice to support replication of the sheep prion agent was analysed and is summarized in Table 2 . Brain homogenate from scrapie-infected ram #8001, which was positive for PK-resistant PrP Sc by Western blotting (Fig. 3a , lanes 3-4), was used to infect TgSShpPrP mice. Injection of nine TgSShpPrP mice by the intracerebral (IC) route with a 10 % brain homogenate from ram # 8001 had a mean incubation period of 167±7 days, indicating that these mice support replication of the ovine prion agent. Western blotting of brain from clinical TgSShpPrP mice demonstrated the presence of PK-resistant PrP Sc (Fig. 3a, lane 8) . In contrast, TgSShpPrP mice showed no clinical signs or PrP Sc after over 520 days following IC injection of either a 10 % normal sheep brain (NSB) homogenate or a 10 % ME7 mouse-adapted scrapie strain brain homogenate (Table 2) .
Semen samples from scrapie-positive rams (# 3272, 7031, 7035 and 8001) were injected IC into TgSShpPrP mice (five mice per semen sample) to bioassay for prion infectivity (Table 2) . One TgSShpPrP mouse from the ram #7031 semen sample group and one from the ram # 3272 semeninjected group showed clinical signs after an incubation period of 310 and 655 days, respectively. Western blotting of the brain from these mice demonstrated PK-resistant PrP Sc ( Fig. 3a and b) . Interestingly, the mouse from the ram # 3272 group did not display any clinical signs at 648 days post-injection (p.i.), but by 655 days p.i. the animal was at the end stage of clinical disease. This is about half the time it typically takes mice to proceed through the same clinical disease course. The remaining mice from these groups, as well as all the mice from the other ram semen-injected groups did not display any clinical disease throughout the entire experiment (.670 days p.i. (Fig. 3a, lane 8; Fig. 4, lane 2) , or semen from ram # 7031 (Fig. 3a, lane 10) and 3272 (Fig. 3b,  lane 6 ) had a PK-resistant PrP Sc pattern consisting of three intensely immunostained bands. A similar pattern of three intensely immunostained bands was also seen in a nonclinical mouse from ram # 3272 semen-injected group at 648 days p.i. (Fig. 3b, lane 4) , just 7 days before another mouse from this group displayed extensive clinical disease. None of the five TgSShpPrP mice/group injected IC with semen from the uninfected rams displayed any clinical signs or PK-resistant PrP Sc by 650 days p.i. (data not shown).
The IHCs performed on all reproductive tissues (prostrate, epididymis, vesicular glands and testes) of the above rams were negative for PrP Sc (Table S2) . Ram #8031 (ARQ/ ARQ) also tested negative by IHC on RAMALT and third eyelid and his brain and all other tissues tested were IHC negative for PrP Sc when euthanized following semen collection (Table S2) . Western blot analysis of brain tissue from ram # 8031 was negative for PK-resistant PrP Sc . Western blotting of the samples following 40 cycles of serial PMCA (sPMCA 40 ) using ram #8031 brain tissue as a seed was also negative for PK-resistant PrP Sc (data not shown) presumably due to the limitations of assay sensitivity. However, using sPMCA 40 , PASA in ram # 8031 brain tissue could be detected and the product (i.e. PrP Sc ) measured by SOFIA with signal intensities (sample/background) of 39.8±2.1 compared with 1.01±0.02 for uninfected control sheep brain.
DISCUSSION
The decision to use rams from the scrapie-positive flock to breed ewes in the sentinel flock resulted from the scarcity and difficulty of finding 136V/V and A/V rams in private certified scrapie-free flocks and the prevalent belief at that time that rams do not transmit scrapie as indicated by the National Scrapie Surveillance Plan (2010). Current USDA Scrapie Eradication Uniform Methods and Rules (2005) do not require the quarantining of flocks following the introduction of exposed rams. Furthermore, the European Food Safety Authority recently reached the same conclusion that the risk of TSE transmission associated with semen and embryos collected from classical scrapie incubating sheep and goats ranges from negligible to low 2) and 648 (lanes 3-4) days p.i. Brain homogenates were also prepared from clinical TgSShpPrP mice at 655 days p.i. Samples were either untreated (lanes 1, 3 and 5) or PK-treated (lanes 2, 4 and 6) prior to Western blotting with mAb 08-6/2F7-2F11. The general conclusion from research to date is that the risk of TSE infection by semen from sheep, goats and cattle is extremely low. Cross-contamination of the semen samples used in this study is one explanation for the infectivity detected in the semen samples from the infected animals. However, TgSShpPrP mice injected with semen from the uninfected rams did not show any sign of disease or the presence of PrP Sc in their brains. The results of the current study demonstrate detection of PASA in semen as well as the presence of PrP Sc in transgenic mice following IC injection. The detection of PASA was performed by using normal brain homogenate as a PrP C source from sheep with a genotype that, in some cases, did not match the genotype of the ram semen samples. It is doubtful that this had any negative influence on PASA amplification of the semen samples since previous studies using mismatched genotypes similar to that for semen did not hinder amplification in blood and urine (Rubenstein et al., 2011 (Rubenstein et al., , 2011 . The detection of the infectious agent in semen by bioassays in ovinized transgenic mice contrasts with the previous report by Sarradin et al. (2008) . Sarradin et al. (2008) examined the role of semen in sheep scrapie transmission by analysing whether semen (i.e. seminal plasma and spermatozoa) could infect and cause disease in the tg338 transgenic mouse line, which overexpresses the permissive V 136 R 154 Q 171 allele of the ovine prion protein.
None of the tg338 mice injected with semen from the VRQ/VRQ genotype or from the ARR/ARR control ram showed any clinical signs during the period of the experiment. The semen samples differed between the two studies, as did the transgenic mouse lines, and most likely the scrapie strain. While both the VRQ and ARQ genotypes are more sensitive to scrapie infection than the ARR genotype, it is conceivable that in the transgenic mouse bioassay the ARQ protein confers greater susceptibility to semen-derived PrP Sc . PrP in sperm is known to undergo different processing than that in brain (Shaked et al., 1999; Ecroyd et al., 2005) . Further, the impact of alanine substitutions can be substantial since the threonine to alanine mutation at position 183 of the human prion protein is linked to a familial disease and results in retention of the prion protein in the endoplasmic reticulum due to structural changes in the protein (Capellari et al., 2000) . Whether or not these factors were responsible for the differences in the final outcomes of these studies remains to be determined. However, it seems premature to rule out the potential of semen-associated-seeding activity as a factor in the transmission of scrapie.
Ram # 8031 is of particular interest. He was euthanized due to an overabundance of ARQ/ARQ and showed no clinical signs at the time of death at age 16 months. All postmortem tissues were IHC negative (Table S2 ) and yet sPMCA 80 and sPMCA 120 followed by SOFIA showed that PASA was present in the semen of this ram. No doubt this ram was infected and subclinical. He had been born and raised in a highly contaminated environment, but possessed a long incubation time genotype. Typical of this strain, he would not have shown clinical signs or positive testing utilizing IHC for 3-5 years. This supports and strengthens our view that the assay used in this study is more sensitive than the presently accepted IHC for early detection of scrapie and could be of value as a live animal test.
We tend to believe that a positive ram was the likely source of the scrapie-infected ewes, if not from semen, then by another type of contact. All but one of the affected ewes were VRQ/VRQ; the incubation time of the 'Caine' strain of scrapie normally in these genotypes is 4-7 months (Bulgin et al., 2006; Hamir et al., 2009) , suggesting that the exposure occurred during the period when the rams were placed with the ewes for breeding. However, the presence of the infectious agent in the semen of the 136AV and VV rams infected with the 'Caine' strain of scrapie, adds another intriguing possibility.
An interesting question is why it took so long for the disease to present itself when the first exposure of the flock during breeding to positive rams occurred 4 years previously. During the preceding 7 years, even though the flock was genetically susceptible, there was no scrapie transmission. The disease onslaught definitely appears to be promoted by the change in genetic composition of the sentinel flock and their degree of susceptibility. When the 136VV and AV rams were first introduced to the flock in 2004, the ewes were all 136AA. Thus, the population slowly shifted to become more susceptible as the 136V genotype was selected for. It is noteworthy that every one of the 136VV ewes in the flock (26 %) was affected. Only one 136AV ewe was affected in spite of the fact that AV ewes made up the majority of the flock (57.9 %). Interestingly, of the VV ewes, two had been in the flock for 3 years, two for 2 years and three were yearlings. In summary, it seems premature to rule out the potential of semen-associated-seeding activity as a factor in transmission of scrapie. In that regard, experiments are currently under way to assess the transmissibility of the PrP Sc from the clinically normal mice that had been infected with sheep semen as well as the material produced by PMCA using a semen seed. These results will demonstrate whether the seeding activity found in semen is competent to promote scrapie transmission. Also, demonstration of natural transmission of scrapie in sheep by semen will have to be confirmed by inoculation of highly susceptible oestrous ewes via artificial insemination using semen collected from positive 'Caine' strain scrapie-infected rams since this may be a strain-specific phenomenon.
METHODS
Sheep care. Facilities, care and procedures met Federal and University of Idaho Animal Care and Use specifications (IACUC protocol #2006-50) . Each sheep was uniquely identified by an ear tag and records were kept for each animal.
Scrapie testing. Unusual behaviour in sentinel animals initiated RAMALT and third eyelid biopsies. Animals dying naturally or euthanized also underwent necropsies and IHC testing (Bulgin et al., 2006) (Supplementary File S1, Table S2 ).
Generation of ovinized transgenic mice. The ovinized transgenic mouse line carrying the Suffolk sheep PrP gene (TgSShpPrP) containing a Kozak ribosome-binding sequence was generated from a sheep PrP cosmid clone in the pWE15 vector (Westaway et al., 1994) . The sheep PrP gene ORF was amplified by PCR using a SalIcontaining (lower case italics) upstream primer (59-TACTGCgtcgacCATGGTGAAAAGCCACATAG-39) containing the Kozak sequence (bold) and a SalI-containing downstream primer (59-ACACGCgtcgacCTATCCTACTATGAGAAA-39). The PCR product was cloned into the pCR2.1-TOPO TA vector (Invitrogen) and sequenced to confirm the fidelity of the amplified material (GenBank accession # U67922) as described previously (Lee et al., 1998) for the Suffolk sheep PrP, which contained the A 136 R 154 Q 171 /ARQ allele. The sequenced DNA was cloned into the SalI sites of the cosSHa.Tet expression vector (Scott et al., 1988) and used for generating the transgenic mouse line TgSShpPrP.
Semen collection and infection of mice. Treatment of animals and sample collection followed an IACUC-approved protocol (protocol # 2010-53) . Semen was collected from control rams (Table 1) by holding a clean small plastic bag over the end of the penis, while stimulating the ram with an hand-held ram electroejaculator.
Semen from scrapie-affected rams (Table 1) was collected by anaesthetizing the rams using intravenous xylazine (0.1 mg per lb body weight) and 5 ml ketamine HCl. They were placed left-side down on a hydraulic table and raised to a comfortable working height. The wool from around the prepuce and adjacent area was shaved and skin scrubbed as for aseptic surgery. The penis was exteriorized and rinsed several times with sterile saline, then catheterized using an appropriate sized sterile polypropylene urinary catheter. The exterior end of the catheter was held over the lip of a sterile conical 15 ml centrifuge tube, while the ram was ejaculated using a hand-held ram electroejaculator. As much semen as possible was collected in this manner, ejaculating the rams several times (collected into a new tube each time) allowing a 3-4 min rest between ejaculations. The semen was centrifuged at 3000 g for 30 min; the supernatant fluid was separated using sterile technique and frozen in 0.5 ml aliquots. The spermatozoa-containing fractions were also frozen and saved.
For injection (Table 2) , TgSShpPrP mice were inoculated IC with 25 ml of a 10 % brain homogenate prepared from normal or scrapieinfected sheep in PBS. For semen supernatant, samples were diluted 1 : 1 with PBS and 25 ml was injected IC. All mice were monitored a minimum of three times a week until termination of the experiments. Signs of clinical disease included initial hypersensitivity followed shortly thereafter by hyposensitivity and lethargy, ataxia, altered gait, disorientation ruffled coat and hunched back. The incubation period is defined as the number of days p.i. to the time of termination. Mice were sacrificed using isoflurane and their brains immediately removed and stored at 280 uC.
PMCA. A 1 % NSB homogenate was used as a source of PrP C for PMCA. Sheep with PRNP genotypes A 136 R 154 R 171 /ARR and A 136 R 154 Q 171 /ARQ were used as a source of brain material for the homogenates. The homogenates, prepared in PBS containing 150 mM NaCl, 1 % Triton X-100, 4 mM EDTA and complete protease inhibitor cocktail (Calbiochem), were centrifuged (400 g, 2 min) and the resulting supernatant was stored at 280 uC. Previous studies on PrP
Sc detection in body fluids demonstrated that genotype matching of the brain material used as a source of PrP C with the source of the infected sample does not affect the extent or efficiency of PMCA (Rubenstein et al., 2010 (Rubenstein et al., , 2011 .
For sPMCA, semen samples (100 ml) were mixed with 10 ml of 1 % NSB homogenate and incubated for 1 h at 37 uC with shaking followed by a 90 s pulse with a model Q-705A sonicator (500 W power output, 40 000 J) (Qsonica). This is defined as one PMCA cycle. Prior to the start of each subsequent cycle, an additional 10 ml of 1 % NSB homogenate was added. At the completion of 10 cycles, 100 ml of the contents was transferred to a new tube and the amplification cycles continued (including the addition of 10 ml of 1 % NSB homogenate). At the completion of 80 serial PMCA cycles (sPMCA 80 ) and 120 serial PMCA cycles (sPMCA 120 ), a 200 ml aliquot of the PMCA products was removed for PK digestion, immunoprecipitation with mAb 8E9 and analysis by SOFIA.
Immunoprecipitation. One hundred microlitres of MagnaBind protein G beads (5 mg ml 21 ) (Pierce) was washed three times with PBS containing 0.2 % Tween 20 (PBST), resuspended in 1 ml PBS, and mixed with 100 mg mAb 8E9 in a final volume of 5 ml PBS. After constant shaking at room temperature for 1 h, the beads were magnetically separated, washed three times with PBST, resuspended in 5 ml PBS and then mixed with a 500 ml sample of the PMCA product. Following incubation on a rotator for 1 h at room temperature, the beads were magnetically separated, washed three times with PBST, resuspended in 500 ml PBS, and heated 100 uC for 15 min. After centrifugation at 16 000 g for 2 min in a microcentrifuge, the supernatant was analysed by SOFIA.
SOFIA. Two hundred microlitres mAb 11F12 (5 mg ml 21 ) was added to each well of a microtitre plate (96-well High Binding plates; Costar) and incubated overnight at 4 uC. After washing the wells three times with PBST, 250 ml blocking buffer (3 % BSA/PBS) was added and incubated at room temperature for 3 h. The wells are washed three times with PBST followed by the addition of 100 ml of each test sample and incubation at room temperature for 2 h. The wells are again washed three times with PBST and 100 ml biotinylated (EZ-Link Sulfo-NHS-LC-Biotinylation kit; Pierce) detection mAb 5D6 (4 mg ml -1 ) was added to each well and incubated at room temperature for 1 h. The wells were washed three times with PBST and incubated with 100 ml streptavidin-rhodamine red-X conjugate (1 : 1000; Invitrogen) for 1 h at 37 uC. Following PBST washes, the wells were incubated for 15 min at 100 uC with 100 ml 1 M NaOH, neutralized with 100 ml 1 M HCl and then transferred to 100 ml microcaps (Drummond Scientific Co.) for laser-based quantification.
Western blot analysis. Ten per cent sheep brain or TgSShpPrP mouse brain homogenates were prepared in PBS containing 1 % Nonidet P-40, 0.5 % sodium deoxycholate, 5 mM EDTA; pH 8.0. A 100 ml sample of each homogenate was digested with 100 mg PK ml 21 at 50 uC for 30 min followed by the addition of 1 % complete protease inhibitor cocktail (Calbiochem). After the addition of 16 Laemmli sample buffer, samples were heated at 100 uC for 10 min Semen PASA, PrP Sc and scrapie infectivity in sheep and the denatured proteins were separated by SDS PAGE. The proteins are transferred to a nitrocellulose membrane and the membrane was blocked overnight in 30 ml PBS containing 5 % non-fat dry milk and 0.1 % Tween 20. The proteins are immunodetected by incubation with 2 mg biotinylated mAb 08-6/2F7-2F11 ml
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, washed three times for 10 min each in 50 ml 16 PBS containing 0.5 % Tween 20 at room temperature, followed by incubation with streptavidin-HRP conjugate (1 : 5000; Invitrogen) for 60 min at room temperature in 16 PBS containing 5 % milk and 0.1 % Tween 20, and three washes for 10 min each in 16 PBS containing 0.5 % Tween 20 at room temperature. Following a wash with distilled H 2 O, proteins were detected using the ECL Supersignal West Dura kit following the manufacturer's instructions (Thermo Scientific).
